Diphtheria with tetanus, pertussis, hepatitis B, poliomyelitis and Hib vaccine
Brand names: Infanrix hexa, Vaxelis
This is the hexavalent (six-in-one) vaccine combining diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis and Haemophilus influenzae type b antigens, given in the UK primary infant immunisation course.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It presents toxoids, acellular pertussis components, hepatitis B surface antigen, inactivated poliovirus and a conjugated Hib polysaccharide to induce protective antibodies against all six targets.
Prescribing in practice
- Do not give to an infant with a confirmed anaphylactic reaction to a previous dose or component, and seek advice for an evolving neurological disorder before the pertussis-containing vaccine.
- It is the routine primary course given by intramuscular injection in infancy and is co-administered with other scheduled vaccines such as meningococcal, pneumococcal and rotavirus per the schedule.
- Apnoea has been reported after immunisation in very premature infants, so the first dose in this group may warrant respiratory monitoring.
Monitoring
Observe for immediate hypersensitivity, monitor very preterm infants for apnoea after the first dose, and advise on expected local and febrile reactions.
Counselling the patient
- Mild fever and injection-site soreness are common; paracetamol may be advised around the routine infant doses.
- Seek help for a high fever or any severe reaction.
- Keep all scheduled appointments to complete the primary course.
Evidence & guidelines
The hexavalent six-in-one vaccine forms the basis of the UK primary infant immunisation schedule as described in national guidance (the Green Book).
Reference: UKHSA Green Book; NHS England immunisation schedule; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Maddrey Discriminant Function (Alcoholic Hepatitis) · Alcoholic Liver Disease
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- FIB-4 Index · Liver Fibrosis
- Maddrey's Discriminant Function for Alcoholic Hepatitis · Hepatology
- Lille Model for Alcoholic Hepatitis · Hepatology
- AST to Platelet Ratio Index (APRI) · Hepatology